Jade Biosciences, Inc. (JBIO)
NASDAQ: JBIO · Real-Time Price · USD
25.81
+1.59 (6.56%)
May 8, 2026, 4:00 PM EDT - Market closed
Jade Biosciences Employees
Jade Biosciences had 55 employees as of December 31, 2025. The number of employees increased by 25 or 83.33% compared to the previous year.
Employees
55
Change
25
Growth
83.33%
Revenue / Employee
n/a
Profits / Employee
-$1,860,636
Market Cap
1.27B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 55 | 25 | 83.33% |
| Dec 31, 2024 | 30 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MannKind | 592 |
| UroGen Pharma | 291 |
| EyePoint | 214 |
| Zenas BioPharma | 167 |
| MoonLake Immunotherapeutics | 130 |
| DBV Technologies | 117 |
| Inventiva | 77 |
| GH Research | 73 |
JBIO News
- 1 day ago - Jade Biosciences files $600M mixed securities shelf - TheFly
- 1 day ago - Jade Biosciences files to sell 39.54M shares of common stock for holders - TheFly
- 2 days ago - Jade Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire
- 12 days ago - Jade Biosciences price target raised to $45 from $35 at H.C. Wainwright - TheFly
- 16 days ago - Jade Biosciences Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 17 days ago - Jade Biosciences appoints Edward Conner as chief medical officer - TheFly
- 17 days ago - Jade Biosciences Appoints Edward R. Conner, M.D. - GlobeNewsWire
- 6 weeks ago - Jade Biosciences price target raised to $35 from $25 at H.C. Wainwright - TheFly